Esther Cubo

Summary

Country: Spain

Publications

  1. ncbi [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease]
    E Cubo
    Departamento de Epidemiologia Aplicada, Instituto de Salud Carlos III, Madrid
    Neurologia 24:15-23. 2009
  2. ncbi What contributes to driving ability in Parkinson's disease
    Esther Cubo
    Neurology Department, Hospital General Yague, Burgos, Spain
    Disabil Rehabil 32:374-8. 2010
  3. ncbi Comparison of tic characteristics between children and adults
    Esther Cubo
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 23:2407-11. 2008
  4. ncbi Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study
    Esther Cubo
    Neurology Department, Clínica Nuestra Señnora del Rosario, Madrid, Spain
    Clin Ther 30:182-9. 2008
  5. ncbi Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease
    Esther Cubo
    Neurology Department, Hospital General Yague, Burgos, Spain
    Mov Disord 25:70-5. 2010
  6. ncbi Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease
    Esther Cubo
    Department of Neurology, Hospital General Yague, Burgos, Spain
    Mov Disord 27:439-42. 2012
  7. ncbi Prevalence of tics in schoolchildren in central Spain: a population-based study
    Esther Cubo
    Department of Neurology, Hospital General Yague, Burgos, Spain
    Pediatr Neurol 45:100-8. 2011
  8. ncbi Clinical correlates of apathy in patients recently diagnosed with Parkinson's disease: the ANIMO study
    Esther Cubo
    Department of Neurology, Complejo Asistencial Universitario, Burgos, Spain
    Neuroepidemiology 38:48-55. 2012
  9. ncbi Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS)
    Pablo Martinez-Martin
    Unit of Neuroepidemiology, National Centre for Epidemiology, ISCIII, Madrid, The Spanish Network HOHSR, Spain
    Qual Life Res 15:597-606. 2006
  10. ncbi Burden of disease related to Parkinson's disease in Spain in the year 2000
    Esther Cubo
    Department of Applied Epidemiology, Carlos III Institute of Health, Madrid, Spain
    Mov Disord 20:1481-7. 2005

Detail Information

Publications19

  1. ncbi [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease]
    E Cubo
    Departamento de Epidemiologia Aplicada, Instituto de Salud Carlos III, Madrid
    Neurologia 24:15-23. 2009
    ..We evaluate the health-related economic burden of patients with Parkinson's disease (PD) and identify the impact of motor and nonmotor symptoms (NMS) and health-related quality of life (HRQL) on the direct costs of PD in Spain...
  2. ncbi What contributes to driving ability in Parkinson's disease
    Esther Cubo
    Neurology Department, Hospital General Yague, Burgos, Spain
    Disabil Rehabil 32:374-8. 2010
    ..To determine the most significant clinical predictors that influence driving ability in Parkinson disease (PD)...
  3. ncbi Comparison of tic characteristics between children and adults
    Esther Cubo
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 23:2407-11. 2008
    ..004) when compared with adults. Tic phenomenology and severity were similar between children and adults, but pharmacological tic management was different, perhaps reflecting a practice trend to avoid medications in children...
  4. ncbi Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study
    Esther Cubo
    Neurology Department, Clínica Nuestra Señnora del Rosario, Madrid, Spain
    Clin Ther 30:182-9. 2008
    ..Striatal cholinergic dysfunction may be important in tics and attention-deficit/hyperactivity disorder (ADHD)...
  5. ncbi Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease
    Esther Cubo
    Neurology Department, Hospital General Yague, Burgos, Spain
    Mov Disord 25:70-5. 2010
    ..This study was designed to evaluate the predominant laterality of motor symptoms and its relationship with cognition and other NMS in idiopathic PD...
  6. ncbi Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease
    Esther Cubo
    Department of Neurology, Hospital General Yague, Burgos, Spain
    Mov Disord 27:439-42. 2012
    ..Classically, clinical trials are based on the placebo-control design. Our aim was to analyze the placebo effect in Huntington's disease...
  7. ncbi Prevalence of tics in schoolchildren in central Spain: a population-based study
    Esther Cubo
    Department of Neurology, Hospital General Yague, Burgos, Spain
    Pediatr Neurol 45:100-8. 2011
    ..The most frequent diagnoses involved chronic motor tics (6.07%) and Tourette syndrome (5.26%). Tic disorders are common in childhood, and the use or nonuse of impairment criteria exerts a significant impact on tic prevalence estimates...
  8. ncbi Clinical correlates of apathy in patients recently diagnosed with Parkinson's disease: the ANIMO study
    Esther Cubo
    Department of Neurology, Complejo Asistencial Universitario, Burgos, Spain
    Neuroepidemiology 38:48-55. 2012
    ..Little is known about apathy in the early stages of Parkinson's disease (PD). We determined the clinical correlates of apathy in a large representative sample of patients recently diagnosed with PD (ANIMO study)...
  9. ncbi Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS)
    Pablo Martinez-Martin
    Unit of Neuroepidemiology, National Centre for Epidemiology, ISCIII, Madrid, The Spanish Network HOHSR, Spain
    Qual Life Res 15:597-606. 2006
    ..In PD, D-FIS is a consistent and valid measure for fatigue, a frequent symptom previously found to impair patients' HRQoL. Fatigue was also linked to depression and disability in this study...
  10. ncbi Burden of disease related to Parkinson's disease in Spain in the year 2000
    Esther Cubo
    Department of Applied Epidemiology, Carlos III Institute of Health, Madrid, Spain
    Mov Disord 20:1481-7. 2005
    ..PD burden in Spain in 2000 was high, with disability being the major contributing factor. Although BPD in Spain was greater than both world and European A subregion BPD, these differences should nevertheless be interpreted with caution...
  11. ncbi Dopaminergic hypersensitivity in patients with Parkinson disease and migraine
    Esther Cubo
    Sanatorio del Rosario, Clinica de la Zarzuela, Department of Neurology, Madrid, Spain
    Clin Neuropharmacol 27:30-2. 2004
    ..These data support the hypothesis that migraine may be associated with dopaminergic hypersensitivity...
  12. ncbi Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation
    Esther Cubo
    Department of Neurology, Sanatorio del Rosario, Clinica de la Zarzuela, Principe de Vergara 53 28006, Madrid, Spain
    Parkinsonism Relat Disord 10:507-10. 2004
    ..In a randomized single blind parallel study, we tested the efficacy of an auditory metronome on walking speed and freezing in Parkinson's disease (PD) patients with freezing gait impairment during their 'on' function...
  13. ncbi Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: the ANIMO study
    Julian Benito-Leon
    Department of Neurology, University Hospital 12 de Octubre, Madrid, Spain
    Mov Disord 27:211-8. 2012
    ..It should be one of the primary concerns among clinicians who provide treatment to individuals affected by PD...
  14. ncbi Validation of screening instruments for neuroepidemiological surveys of tic disorders
    Esther Cubo
    Neurology Department, General Yague Hospital, Burgos, Spain
    Mov Disord 26:520-6. 2011
    ....
  15. ncbi Comparison of office-based versus home Web-based clinical assessments for Parkinson's disease
    Esther Cubo
    Neurology Department, Complejo Asistencial Universitario Burgos, Burgos, Spain
    Mov Disord 27:308-11. 2012
    ..The feasibility and validity of Web-based assessments in Parkinson's disease is unknown. The objectives of this study were to develop and to compare home Web-based assessments with office-based assessments...
  16. ncbi Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD)
    Pablo Martinez-Martin
    Neuroepidemiology Unit, National Center for Epidemiology, Carlos III Institute of Public Health, Madrid, Spain
    Mov Disord 21:208-14. 2006
    ..90) and convergent (r>0.75) and known-groups validity. The CISI-PD is a valid and reliable measure that expands the information obtained via the CGIS...
  17. ncbi Striatal dopamine function in a family with multiple SCA-3 phenotypes
    Esther Cubo
    Department of Neurology, Hospital General Yague, Avda Cid 96, 09005, Burgos, Spain
    J Neurol 258:308-10. 2011
    ..SCA-3 can present with a levodopa responsive parkinsonism phenotype, and an abnormal DAT scan showing predominant impairment of presynaptic dopamine function...
  18. ncbi Transcultural comparison of psychogenic movement disorders
    Esther Cubo
    Sanatorio del Rosario, Clinica de la Zarzuela, Neurology Department, Madrid, Spain
    Mov Disord 20:1343-5. 2005
    ..Gait and speech dysfunctions were distributed similarly in both countries. We found action tremor to be the most frequent PMD in both countries...
  19. ncbi Wheeled and standard walkers in Parkinson's disease patients with gait freezing
    Esther Cubo
    Neurology Department, Clínica del Rosario, Principe De Vergara 53, 28006, Madrid, Spain
    Parkinsonism Relat Disord 10:9-14. 2003
    ..Compare the efficacy of two walking assistance devices (wheeled walker and standard walker) to unassisted walking for patients with PD and gait freezing...